<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04411082</url>
  </required_header>
  <id_info>
    <org_study_id>IMR-BTL-201</org_study_id>
    <secondary_id>2019-002989-12</secondary_id>
    <nct_id>NCT04411082</nct_id>
  </id_info>
  <brief_title>A Study of IMR-687 in Subjects With Beta Thalassemia</brief_title>
  <official_title>A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects With Beta Thalassemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imara, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imara, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety,&#xD;
      tolerability, PK, and PD of IMR-687 (phosphodiesterase (PDE) 9 inhibitor) administered once&#xD;
      daily (qd) orally for 36 weeks in 2 populations of adult subjects with β-thalassemia:&#xD;
      Population 1 (Transfusion Dependent Thalassemia (TDT) subjects) and Population 2&#xD;
      (Non-Transfusion Dependent Thalassemia (NTDT) subjects).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Double-Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>IMR-687 Safety and tolerability</measure>
    <time_frame>Baseline to Week 40</time_frame>
    <description>Incidence and severity of Adverse Events&#xD;
Incidence and severity of Serious Adverse Events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TDT Patients: Reduction in red blood cell (RBC) transfusion burden</measure>
    <time_frame>Week 12 to Week 36</time_frame>
    <description>Proportion of patients with ≥20% hematological improvement (as measured by reduced transfusion burden) from Week 12 to Week 24, Week 24 to Week 36, and Week 12 to Week 36, compared to the 12 weeks prior to Baseline (Day 1).&#xD;
Proportion of patients with ≥33% hematological improvement (as measured by reduced transfusion burden) from Week 12 to Week 24, Week 24 to Week 36, and Week 12 to Week 36, compared to the 12 week prior to Baseline (Day 1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TDT Patients: Mean number of transfusion events</measure>
    <time_frame>Baseline to Week 36</time_frame>
    <description>a. Mean number of transfusion events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TDT and NTDT Patients: Mean change in ICT dose and Serum ferritin levels</measure>
    <time_frame>Baseline to Week 36</time_frame>
    <description>a. Mean change in ICT daily dose and serum ferritin levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NTDT Patients: Change in Hb</measure>
    <time_frame>Baseline to Week 36</time_frame>
    <description>Proportion of subjects with an increase from baseline of ≥1.0 g/dL in mean Hb values at Week 12 to Week 24 and Week 24 to Week 36 in the absence of transfusions.&#xD;
Mean change from baseline in mean Hb values at Week 12 to Week 24 and Week 24 to Week 36 in the absence of transfusions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NTDT Patients: Mean change in HbF</measure>
    <time_frame>Baseline to Week 36</time_frame>
    <description>Mean change from baseline in mean HbF values at Week 12 to Week 24 and Week 24 to Week 36 in the absence of transfusions.&#xD;
Proportion of subjects with an increase from baseline of ≥3% in mean HbF values at Week 12 to Week 24 and Week 24 to Week 36 in absence of transfusions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TDT and NTDT Patients: PK Parameter Cmax</measure>
    <time_frame>Baseline to Week 36</time_frame>
    <description>a. Peak Plasma Concentration (Cmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TDT and NTDT Patients: PK Parameter AUC 0-24</measure>
    <time_frame>Baseline to Week 36</time_frame>
    <description>a. Area Under the Plasma Concentration versus Time Curve (AUC) from time 0 to 24 hours</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>β Thalassemia</condition>
  <arm_group>
    <arm_group_label>Lower Dose IMR-687</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral administration of once daily IMR-687</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Higher dose IMR-687</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral administration of once daily IMR-687</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral administration of once daily placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IMR-687</intervention_name>
    <description>Oral administration of once daily IMR-687</description>
    <arm_group_label>Higher dose IMR-687</arm_group_label>
    <arm_group_label>Lower Dose IMR-687</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral administration of once daily Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Documented diagnosis of β-thalassemia or HbE/ β-thalassemia in their medical history.&#xD;
             Concomitant alpha gene deletion, duplication, or triplication is allowed.&#xD;
&#xD;
          2. Documentation of the dates of transfusion events and the number of all pRBC units per&#xD;
             event within the 12 weeks prior to the Baseline (Day 1) visit. .&#xD;
&#xD;
          3. Must be willing and able to complete all study assessments and procedures, and to&#xD;
             communicate effectively with the investigator and site staff.&#xD;
&#xD;
          4. TDT Subjects: subjects must be regularly transfused, defined as &gt;3 to 10 pRBC units in&#xD;
             the12 weeks prior to Baseline (Day 1) visit and no transfusion-free period for &gt;35&#xD;
             days during that period.&#xD;
&#xD;
          5. NTDT subjects: Subjects must be transfusion independent, defined as 0 to ≤3 units of&#xD;
             pRBCs received during the 12-week period prior to the Baseline (Day 1) visit, must not&#xD;
             be on a regular transfusion program, must be RBC transfusion-free for at least ≥ 4&#xD;
             weeks prior to randomization, and must not be scheduled to start a regular&#xD;
&#xD;
          6. hematopoietic stem cell transplantation within 9 months.&#xD;
&#xD;
          7. NTDT subjects: Subjects must have Hb ≤10.0 g/dL at Screening; the screening Hb sample&#xD;
             must be collected 7 to 28 days prior to randomization. Hb values within 21 days&#xD;
             post-transfusion will be excluded.&#xD;
&#xD;
          8. ECOG performance score of 0 to 1&#xD;
&#xD;
          9. Female subjects must not be pregnant, or breastfeeding and be highly unlikely to&#xD;
             become pregnant. Male subjects must be unlikely to impregnate a partner.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of α-thalassemia (e.g., hemoglobin H [HbH]) or hemoglobin S (HbS)/ β&#xD;
             thalassemia.&#xD;
&#xD;
          2. Body mass index (BMI) &lt;17.0 kg/m2 or a total body weight &lt;45 kg; or BMI &gt;35 kg/m2&#xD;
&#xD;
          3. Subjects with known active hepatitis A, hepatitis B, or hepatitis C, with active or&#xD;
             acute event of malaria, or who are known to be positive for human immunodeficiency&#xD;
             virus (HIV).&#xD;
&#xD;
          4. Stroke requiring medical intervention ≤24 weeks prior to randomization.&#xD;
&#xD;
          5. Platelet count &gt;1000 × 109/L.&#xD;
&#xD;
          6. Participated in another clinical study of an investigational agent (or device) within&#xD;
             30 days or 5-half-lives of date of informed consent, whichever is longer, or is&#xD;
             currently participating in another study.&#xD;
&#xD;
          7. For Subjects on iron chelation therapy (ICT) at the time of ICF signing, initiation of&#xD;
             ICT less than 24 weeks before the predicted randomization date.&#xD;
&#xD;
          8. Prior exposure to sotatercept or luspatercept, IMR-687, or gene therapy within 6&#xD;
             months prior to randomization (Day 1).&#xD;
&#xD;
          9. Subjects who have major organ damage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Attie, MD</last_name>
    <role>Study Director</role>
    <affiliation>Imara, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Subhash Kakani</last_name>
    <phone>617-206-2020</phone>
    <email>info@imaratx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Megan McNeill</last_name>
    <phone>617-206-2020</phone>
    <email>info@imaratx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>American Institute of Research - Whittier</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omkar Marathe, MD</last_name>
      <phone>562-693-4477</phone>
      <email>omarathe@airesearch.us</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sujit Sheth</last_name>
      <phone>212-746-4522</phone>
      <email>shethsu@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Kwiatkowski</last_name>
      <phone>215-590-3437</phone>
      <email>kwiatkowski@email.chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Blake Weil</last_name>
      <phone>267-426-7634 x67634</phone>
      <email>weilb@chop.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farzana Sayani</last_name>
      <phone>215-615-6555</phone>
      <email>farzana.sayani@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <state>Hovedstaden</state>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Glenthoj</last_name>
      <phone>+45 3868 6365</phone>
      <email>andreas.glenthoej@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Byron Guldhammer</last_name>
      <phone>+45 38686410</phone>
      <email>lisa.byron.guldhammer@regionh.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire du Cancer de Toulouse Oncopole</name>
      <address>
        <city>Toulouse cedex 9</city>
        <state>Haute-Garonn</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Congoul</last_name>
      <phone>+33531156209</phone>
      <email>cougoul.pierre@iuct-oncopole.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle Libourel</last_name>
      <phone>+33531156357</phone>
      <email>libourel.isabelle@iuct-oncopole.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon Cedex 03</city>
        <state>Rhone</state>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanna Cannas</last_name>
      <phone>+33 472 117 413</phone>
      <email>giovanna.cannas@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Merazga Salima</last_name>
      <phone>+33 4 72 11 03 41</phone>
      <email>salima.merazga@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure Joseph</last_name>
      <phone>+33144494000</phone>
      <email>laure.joseph@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Manceau</last_name>
      <phone>+33 1 71 19 64 35</phone>
      <email>sandra.manceau-ext@aphp.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>M. Zodelava Hematology Centre</name>
      <address>
        <city>Tbilisi</city>
        <state>Borjomi</state>
        <zip>0112</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mamia Zodelava, MD</last_name>
      <phone>+995 599-10-60-10</phone>
      <email>mzodelava@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Mariam Kurtsadze</last_name>
      <phone>+995 597-30-20-19</phone>
      <email>mariamkurtsadze1@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>National Center of Surgery</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Levani Makhaldiani, MD</last_name>
      <phone>+995322251991</phone>
      <email>levan.makhaldiani@aversi.ge</email>
    </contact>
    <contact_backup>
      <last_name>Ketevan Sibashvili</last_name>
      <phone>+995568394439</phone>
      <email>keti.sibashvili@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medinvest - Institute of Hematology and Transfusiology</name>
      <address>
        <city>Tbilisi</city>
        <zip>0186</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genadi Iosava, MD</last_name>
      <phone>+995 3-2395111</phone>
      <email>genadiiosava@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Nana Gogokhia</last_name>
      <phone>+995599106575</phone>
      <email>gogokhiananika@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aghia Sofia General Children's Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attica</state>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonis Kattamis</last_name>
      <phone>+30 21 3201 3000</phone>
      <email>ankatt@med.uoa.gr</email>
    </contact>
    <contact_backup>
      <last_name>Eleni Paltoglou</last_name>
      <phone>+306971572581</phone>
      <email>elinapalt@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Laiko General Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <state>Attica</state>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ersi Voskaridou-Dimoula</last_name>
      <phone>+30 2132060800</phone>
      <email>ersi.voskaridou@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Evanthia Mitsopoulou</last_name>
      <phone>+30 6978610794</phone>
      <email>evamits@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ippokrateio General Hospital of Thessaloniki</name>
      <address>
        <city>Thessaloníki</city>
        <state>Central Macedonia</state>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Efthymia Vlachaki</last_name>
      <phone>+30 6941586121</phone>
      <email>efivlachaki@yahoo.gr</email>
    </contact>
    <contact_backup>
      <last_name>Ioanna Christodoulou</last_name>
      <phone>+30 6972000573</phone>
      <email>g.christod78@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Patras</name>
      <address>
        <city>Patra</city>
        <state>Peloponnese</state>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Kourakali</last_name>
      <phone>+30 2613 603000</phone>
      <email>akourakli@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Eleni Kalyvioti</last_name>
      <phone>+302613604169</phone>
      <email>kalyviotielena@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <state>Haifa District</state>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdalla Khalil</last_name>
      <phone>+97247774718</phone>
      <email>k_abdalla@rambam.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Niva Tuma</last_name>
      <phone>972-4-7774716</phone>
      <email>n_tuma@rambam.health.gov.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hadassah University Hospital Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <state>Jerusalem District</state>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neta Goldschmidt, MD</last_name>
      <phone>+97226776744</phone>
      <email>neta@hadassah.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Reut Maimon</last_name>
      <phone>+972 02-6776765</phone>
      <email>reutm@hadassah.org.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Galilee Medical Center</name>
      <address>
        <city>Nahariya</city>
        <state>Northern District</state>
        <zip>2210001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Kuperman, MD</last_name>
      <phone>+972 507887457</phone>
      <email>amirk@gmc.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Hila Bali</last_name>
      <phone>+97249107168</phone>
      <email>hilab@gmc.gov.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Emek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carina Levin</last_name>
      <phone>+972 4-6494 000</phone>
      <email>levin_c@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Adi Hendel</last_name>
      <phone>+972-4-6494044</phone>
      <email>adisa5@clalit.org.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>9103401</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shoshana Revel Vilk</last_name>
      <phone>+97226777408</phone>
      <email>svilk@szmc.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Majdolen Istaiti</last_name>
      <phone>+972-2-5645681</phone>
      <email>joleenist@szmc.org.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ente Ospedaliero Ospedali Galliera</name>
      <address>
        <city>Genova</city>
        <state>Genoa</state>
        <zip>16128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gian Luca Forni</last_name>
      <phone>+390105634560</phone>
      <email>gianluca.forni@galliera.it</email>
    </contact>
    <contact_backup>
      <last_name>Giulia Albasini</last_name>
      <phone>+39 010 5634583</phone>
      <email>giulia.albasini@galliera.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Giuseppe Brotzu</name>
      <address>
        <city>Orbassano</city>
        <state>Turin</state>
        <zip>10043</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffaella Origa</last_name>
      <phone>+3907052965515</phone>
      <email>raffaella.origa@aob.it</email>
    </contact>
    <contact_backup>
      <last_name>Antonietta Zappu</last_name>
      <email>antonietta.zappu@aob.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria - Università degli Studi della Campania Luigi Vanvitelli</name>
      <address>
        <city>Orbassano</city>
        <state>Turin</state>
        <zip>10043</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silverio Perrotta</last_name>
      <phone>+390815665421</phone>
      <email>silverio.perrotta@unicampania.it</email>
    </contact>
    <contact_backup>
      <last_name>Maria Pennisi</last_name>
      <email>mariapennisi96@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero - Universitaria San Luigi Gonzaga</name>
      <address>
        <city>Orbassano</city>
        <state>Turin</state>
        <zip>10043</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Ferrero</last_name>
      <email>giovannibattista.ferrero@unito.it</email>
    </contact>
    <contact_backup>
      <last_name>Andrea Piolatto</last_name>
      <email>andrea.piolatto@unito.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanna Graziadei</last_name>
      <phone>+39 0255033493</phone>
      <email>giovanna_graziadei@yahoo.it</email>
    </contact>
    <contact_backup>
      <email>giovanna.graziadei@policlinico.mi.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Chronic Care Center</name>
      <address>
        <city>Hazmiyeh</city>
        <zip>213</zip>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Taher</last_name>
      <phone>+9615455102</phone>
      <email>ataher@aub.edu.lb</email>
    </contact>
    <contact_backup>
      <last_name>Rita Daderian</last_name>
      <phone>96170971938</phone>
      <email>daderian.r7@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Sultanah Aminah Johor Bharu</name>
      <address>
        <city>Johor Bahru</city>
        <state>Johor</state>
        <zip>80100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soo Min Lim</last_name>
      <phone>+60125398815</phone>
      <email>soominlim@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Siti Masnirah Alwi</last_name>
      <phone>+607-2257000</phone>
      <phone_ext>2782</phone_ext>
      <email>masnirah@clinicalresearch.my</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Sultanah Bahiyah</name>
      <address>
        <city>Alor Setar</city>
        <state>Kedah</state>
        <zip>05460</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Keng Liew</last_name>
      <phone>+60124281842</phone>
      <email>liewhongkeng@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Poh Tiew Neoh</last_name>
      <phone>+604-7407391</phone>
      <email>poh.tiew@clinicalresearch.my</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Pulau Pinang</name>
      <address>
        <city>George Town</city>
        <state>Penang</state>
        <zip>10450</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ai Sim Goh</last_name>
      <phone>+60174122502</phone>
      <email>gohaisim@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Faizah Harun</last_name>
      <phone>+6013-845 7328</phone>
      <email>faizah.harun@clinicalresearch.my</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Raja Permaisuri Bainun</name>
      <address>
        <city>Ipoh</city>
        <state>Perak</state>
        <zip>30450</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamini Kirubamoorthy</last_name>
      <phone>+60193255800</phone>
      <email>kkamini20@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Pavithrah Shunmugam</last_name>
      <phone>+605-208 5000</phone>
      <email>pavithrahshunmugam@clinicalresearch.my</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Queen Elizabeth - Kota Kinabalu</name>
      <address>
        <city>Kota Kinabalu</city>
        <state>Sabah</state>
        <zip>88586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lily Wong</last_name>
      <phone>+60138609250</phone>
      <email>lilwongll@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Stella Stephenie Macain</last_name>
      <phone>+60173413348</phone>
      <email>stellastephenie@clinicalresearch.my</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Umum Sarawak</name>
      <address>
        <city>Kuching</city>
        <state>Sarawak</state>
        <zip>93586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee Ping Chew</last_name>
      <phone>+60165518129</phone>
      <email>leepingc@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Irene Anak Gitek</last_name>
      <phone>+6082 276820</phone>
      <email>ireneg.crc@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hôpital d'Enfants Rabat</name>
      <address>
        <city>Rabat</city>
        <zip>10100</zip>
        <country>Morocco</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laila Hessissen</last_name>
      <phone>+212661220366</phone>
      <email>lailahsn@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hayat El Moufakkir</last_name>
      <phone>+212 6 64 30 36 00</phone>
      <email>hayatchop@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Amsterdam Universitair Medische Centra - Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <state>North Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bart Biemond</last_name>
      <phone>+31205662096</phone>
      <email>b.j.biemond@amc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Cheyenne Pierie</last_name>
      <phone>020 - 5668195</phone>
      <email>hemat.trial@amc.uva.nl</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hagaziekenhuis Van Den Haag - Leyweg</name>
      <address>
        <city>Den Haag</city>
        <state>South Holland</state>
        <zip>2545 AA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Louis Kerkhoffs</last_name>
      <phone>+31702102556</phone>
      <email>j.kerkhoffs@hagaziekenhuis.nl</email>
    </contact>
    <contact_backup>
      <last_name>Okke Eissen</last_name>
      <phone>0702101844</phone>
      <email>researchhematologie@hagaziekenhuis.nl</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hôpital Universitaire Farhat Hached</name>
      <address>
        <city>Sousse</city>
        <zip>4000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abderrahim Khelif</last_name>
      <phone>+21698544300</phone>
      <email>abkhelif@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Neila Miled</last_name>
      <phone>+21628916825</phone>
      <email>neila.miled@aouina-conseil.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre National de Greffe de la Moelle Osseuse</name>
      <address>
        <city>Tunis</city>
        <zip>1006</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monia Ouederni</last_name>
      <phone>+21622161689</phone>
      <email>moniahasan@yahoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Neila Miled</last_name>
      <phone>+21628916825</phone>
      <email>neila.miled@aouina-conseil.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Aziza Othmana</name>
      <address>
        <city>Tunis</city>
        <zip>1008</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Balkis Meddeb</last_name>
      <phone>+216 71 260 326</phone>
      <email>meddeb.balkis@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Meriam Achour</last_name>
      <phone>+216 20 80 86 42</phone>
      <email>mitagrette@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Akdeniz Üniversitesi</name>
      <address>
        <city>Mersin</city>
        <state>Icel</state>
        <zip>33110</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osman Alphan Kupesiz</last_name>
      <phone>+90 242 249 6000</phone>
      <email>akupesiz@akdeniz.edu.tr</email>
    </contact>
    <contact_backup>
      <last_name>Zeynep Ozturk</last_name>
      <phone>+905057538932</phone>
      <email>zbolat@akdeniz.edu.tr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mersin Üniversitesi Tıp Fakültesi</name>
      <address>
        <city>Mersin</city>
        <state>Icel</state>
        <zip>33110</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selma Unal</last_name>
      <phone>+90 324-337-43-00</phone>
      <email>unalselma@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Baransel Yalcin</last_name>
      <phone>+90 536 567 60 89</phone>
      <email>baransel.yalcin@atlascro.com.tr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hacettepe Üniversitesi</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sule Unal Cangul</last_name>
      <phone>+90 312 305 1170</phone>
      <email>suleunal@hacettepe.edu.tr</email>
    </contact>
    <contact_backup>
      <last_name>Gamze Kirmizibayrak</last_name>
      <phone>+90 538 053 53 67</phone>
      <email>gamzeezgi.kirmizibayrak@monitorcro.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ege Universitesi Tip Fakultesi</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yesim Aydinok</last_name>
      <phone>+90 232 390 1188</phone>
      <email>yesim.aydinok@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Rojda Tanman</last_name>
      <phone>+90 531 515 99 69</phone>
      <email>rojda.tanman@quadro-cro.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Whittington Health NHS Trust</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>N19 5NF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farrukh Shah</last_name>
      <phone>+442072723070</phone>
      <email>farrukh.shah@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Ana Zuriaga Alvaro</last_name>
      <phone>+440207 288 3896</phone>
      <email>ana.alvaro@nhs.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Perla Eleftheriou</last_name>
      <phone>+44 (0) 20-3456-7890</phone>
      <email>perla.eleftheriou@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Francisca Asalu</last_name>
      <phone>+44 07950857983</phone>
      <email>fasalu@nhs.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Manchester University NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>England</state>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nandini Sadasivam</last_name>
      <phone>+44 0161 7015925</phone>
      <email>nandini.sadasivam@mft.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Sophia Boydell</last_name>
      <phone>+44 0161 701 6688</phone>
      <email>sophia.boydell@mft.nhs.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>France</country>
    <country>Georgia</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Lebanon</country>
    <country>Malaysia</country>
    <country>Morocco</country>
    <country>Netherlands</country>
    <country>Tunisia</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2020</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transfusion</keyword>
  <keyword>TDT</keyword>
  <keyword>NTDT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>beta-Thalassemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

